Freeing the Competition: Will Aumolertinib (AENEAS) Have a Fighting Chance Against Osimertinib (FLAURA)?
David J BenjaminMisako NagasakaPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)